Genomics BioSci & Tech. Co.Ltd.

TWO:4195 Taiwan Biotechnology

Market Cap

$53.10 Million

NT$1.76 Billion TWD

Market Cap Rank

#22479 Global

#1288 in Taiwan

Share Price

NT$24.25

Change (1 day)

+0.21%

52-Week Range

NT$14.65 - NT$28.70

All Time High

NT$28.70

Genomics BioSci & Tech. Co.Ltd. - Asset Resilience Ratio

Latest as of June 2024: 1.45%

Genomics BioSci & Tech. Co.Ltd. (4195) has an Asset Resilience Ratio of 1.45% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$18.50 Million

Cash + Short-term Investments

Total Assets

NT$1.28 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Genomics BioSci & Tech. Co.Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Genomics BioSci & Tech. Co.Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$18.50 Million	1.45%
Total Liquid Assets	NT$18.50 Million	1.45%

Asset Resilience Insights

Limited Liquidity: Genomics BioSci & Tech. Co.Ltd. maintains only 1.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.